See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Spex Capital is an investment management firm specialized in advancing disruptive early-stage ventures to deliver breakthroughs globally, with a focus on digital healthcare and med-tech. The firm aims to bridge promising companies to help them navigate and overcome the 'valley of death' - the funding gap that prevents many innovative ventures from accessing appropriate opportunities in their early stages. Through their €100M Spex Venture HealthTech Fund, they identify, partner with, and fund the next generation of early-stage digital healthcare and med-tech start-ups, accelerating their route to commercialisation to improve healthcare systems globally. Their impact-driven reporting metrics align with the United Nations Sustainable Development Goals and they support guidance from the Global Impact Investing Network, IRIS+ standards, and the Impact Management Project frameworks. The fund is designated as an Article 9 impact fund under the EU's Sustainable Finance Disclosure Regulation (SFDR).
Notable quotes
“Digital transformation is accelerating at pace, driven by both systemic pressures and breakthrough innovations. With this fund, our network of global partnerships, together with our team's expertise and a broad network of high calibre Senior Advisors, we will have unparalleled access to invest in the best startups shaping the future of health systems worldwide.”
“Even before Covid-19, the drive for countries to make better use of digital technology in healthcare had already begun.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Sano Genetics | Series A | $11m | 2022-03 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| MMC Ventures | 1 |
| Episode 1 Ventures | 1 |
| Seedcamp | 1 |
| Redalpine Venture Partners | 1 |
| Spark Capital | 1 |
Fit check
Is Spex Capital Ltd. a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit